SARS-CoV-2 in Nursing Homes after 3 Months of Serial, Facilitywide Point Prevalence Testing, Connecticut, USA.
COVID-19
Connecticut
RT-PCR
SARS-CoV-2
United States
coronavirus disease
diagnostics
epidemiology
long-term care facility
nursing home
outbreak
prevalence
respiratory infections
severe acute respiratory syndrome coronavirus 2
universal testing
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
entrez:
26
4
2021
pubmed:
27
4
2021
medline:
22
6
2021
Statut:
ppublish
Résumé
Nursing homes house populations that are highly vulnerable to coronavirus disease. Point prevalence surveys (PPSs) provide information on the severe acute respiratory syndrome coronavirus 2 infection status of staff and residents in nursing homes and enable isolation of infectious persons to halt disease spread. We collected 16 weeks of public health surveillance data on a subset of nursing homes (34/212) in Connecticut, USA. We fit a Poisson regression model to evaluate the association between incidence and time since serial PPS onset, adjusting for decreasing community incidence and other factors. Nursing homes conducted a combined total of 205 PPSs in staff and 232 PPSs in residents. PPS was associated with 41%-80% reduction in incidence rate in nursing homes. Our findings provide support for the use of repeated PPSs in nursing home staff and residents, combined with strong infection prevention measures such as cohorting, in contributing to outbreak control.
Identifiants
pubmed: 33900171
doi: 10.3201/eid2705.204936
pmc: PMC8084507
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1288-1295Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Références
J Am Geriatr Soc. 2021 Jan;69(1):30-36
pubmed: 33034039
Epidemiol Rev. 2018 Jun 1;40(1):105-120
pubmed: 29648594
MMWR Morb Mortal Wkly Rep. 2020 Jul 10;69(27):882-886
pubmed: 32644985
J Infect. 2021 Jan;82(1):159-198
pubmed: 32768449
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1288-1295
pubmed: 32966272
MMWR Morb Mortal Wkly Rep. 2020 Aug 28;69(34):1177-1179
pubmed: 32853190
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32574139
Lancet Microbe. 2021 Jan;2(1):e13-e22
pubmed: 33521734
JAMA. 2020 Sep 15;324(11):1101-1103
pubmed: 32790860
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
JAMA Intern Med. 2021 Jan 1;181(1):127-129
pubmed: 32662818
MMWR Morb Mortal Wkly Rep. 2020 Aug 11;69(32):1095-1099
pubmed: 32790655
Am J Infect Control. 2020 Dec;48(12):1552-1555
pubmed: 32622836
Euro Surveill. 2020 Jun;25(22):
pubmed: 32524949
Clin Infect Dis. 2020 Jul 20;:
pubmed: 32687150
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1296-1299
pubmed: 32941413
MMWR Morb Mortal Wkly Rep. 2020 Jul 03;69(26):836-840
pubmed: 32614816
J Am Geriatr Soc. 2020 Oct;68(10):2153-2162
pubmed: 32735036
Health Aff (Millwood). 2021 Jan;40(1):42-52
pubmed: 33211536
MMWR Morb Mortal Wkly Rep. 2020 May 29;69(21):651-655
pubmed: 32463809
Clin Infect Dis. 2021 May 4;72(9):e394-e396
pubmed: 32687198
J Infect Dis. 2021 Feb 13;223(3):381-388
pubmed: 32889532